Kuang He

Kuang is Vice President in the Seed Investments team where she enjoys infusing a dash of creativity and storytelling into the serious business of venture creation. Prior to Novo Seeds, she spent four years at Sofinnova Partners evaluating clinical-stage investment opportunities and steering portfolio companies through challenges in regulatory pathways, market access, and commercialization. 

Kuang holds a Ph.D. in Biochemistry from Indiana University, Bloomington and was recognized with a Clinical and Translational Science Award by the National Institutes of Health (NIH) during her postdoctoral training in the Division of Hematology/Oncology at the University of Michigan.